In November 2024, I was diagnosed with Adult-Onset Diabetes. In addition to Metformin, I began a low-dose weekly semaglutide regimen—Ozempic. I will be honest: initially, I was resistant. I wrongly believed that relying on medication was a sign of personal weakness. I could not have been more mistaken.
By November 2025, I had lost 30 pounds. My blood pressure medications were significantly reduced, and my cholesterol levels dramatically improved. Today, my LDL, HDL, A1C, and daily glucose levels are all comfortably within the normal range. I have lost two inches around my waist, one inch from my neck, and I can once again fit into the tuxedo I wore at my wedding 42 years ago.
Never in my medical career have I been so profoundly impressed by the efficacy of a medication—whether taken personally or prescribed to a patient.
Of course, the semaglutide did not work in isolation. Diligent dietary modifications and consistent exercise were essential components of my success. However, the medication's unique ability to quiet "food noise," reduce cravings, and assist with portion control made sustainable progress achievable in a way it never had been before. For me, the mild, temporary gastrointestinal side effects were a small price to pay for such transformative health results.,
Warmly,
Jonathan Berman, MD Chief Surgeon,
Berman Plastic Surgery & Spa
